U.S. Nuclear Regulatory Commission
Technical Assistance Request, MPI Pharmacy Services, Inc., License Amendmen t Regarding Authorized Users
HPPOS-282 PDR-9306160177
Title: Technical Assistance Request, MPI Pharmacy
Services, Inc., License Amendment Regarding Authorized Users
See the memorandum from J. E. Glenn to R. R. Bellamy dated
January 25, 1993. This memo responds to a technical
assistance request, dated November 5, 1992, to review an
amendment request by MPI Pharmacy Services, Inc. The
amendment request would permit any authorized user on a MPI
Pharmacy Services, Inc., license to be an authorized user
at the Livingston, New Jersey, nuclear pharmacy (License
No. 29-28341-02MD). The licensee indicates a copy of the
NRC or Agreement State license specifically listing the
authorized user will be kept at the Livingston pharmacy for
3 years or until the individuals are specifically listed on
the Livingston license. The licensee's request to permit
any authorized user on an MPI Agreement State license to be
an authorized user on the Livingston license cannot be
approved at this time. Reciprocal recognition of Agreement
State authorizations may be appropriate at a later date,
but currently drafted regulations may change the training
and experience requirements for NRC licensees in the near
future.
While the remaining part of the licensee's request,
permitting any authorized user on an NRC MPI license to be
an authorized user on the Livingston license, could be
approved, it is recommended that the licensee take the
following alternative approach. The licensee should
consider selecting one of their NRC licenses as the
document that lists all authorized users. The other NRC
licenses could then be amended to authorize use of an
authorized user on the list. This system has been used
successfully by other commercial nuclear pharmacies. It
reduces NRC's review of the proposed authorized user's
training and experience to a single review. It also
minimizes MPI's amendment application fees, and review time
while it maximizes MPI's flexibility in assigning and
reassigning authorized users to specific nuclear
pharmacies. If the licensee does not want to amend all the
other licenses at one time, individual licenses can be
amended as specific changes or renewals are needed. This
system can also be used later to institute generic changes
that may be applicable to all licenses.
Regulatory references: 10 CFR 30, 10 CFR 35, License
Conditions
Subject codes: 1.3, 12.2
Applicability: Byproduct Material

